Once-daily Helicobacter pylori treatment to family members of gastric cancer patients.
Coelho
L G
LG
Passos
M C
MC
Martins
G M
GM
Bueno
M L
ML
Gomes
B S
BS
Lopes
L G
LG
Castro
L P
LP
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000328:Adult; D000897:Anti-Ulcer Agents / Q000008:administration & dosage*; D017291:Clarithromycin / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005190:Family; D005260:Female; D005664:Furazolidone / Q000008:administration & dosage*; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori / Q000187:drug effects; D006801:Humans; D064747:Lansoprazole; D008297:Male; D009853:Omeprazole / Q000008:administration & dosage / Q000031:analogs & derivatives*; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000382:microbiology
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents; D064747:Lansoprazole; D005664:Furazolidone; D017291:Clarithromycin; D009853:Omeprazole